Greg has been involved in the healthcare industry for almost 30 years working in a number of roles including licensed pharmacist, market access consultant, market research and access leader in the biopharmaceutical industry. He has extensive experience in the areas of oncology, hematology, bone marrow transplant, endocrinology, Hepatitis C and several other therapeutic areas.
Among his significant accomplishments are developing and implementing the market access launches for several blockbuster products including Neulasta®, Aranesp® Oncology and Genotropin®. In addition, Greg established the Covance Specialty Pharmacy during his tenure at Covance where he was a member of the Executive Leadership Team.
Greg has prior experience at Covance (VP, Patient and Provider Services), Interactive Clinical Intelligence (VP), Amgen (Director, Reimbursement and Access), CellPro (Director, Product Economics) and Pharmacia & Upjohn (Associate Director, Third Party Payment Relations).
He has the following degrees: B.S. Pharmacy (Univ. of Arkansas), Juris Doctorate (University of Arkansas) and LLM in Health Law (Loyola of Chicago School of Law).